Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BOLT compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
BOLT
Bolt Biotherapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
BOLT
Bolt Biotherapeutics, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only BOLT
0
None
Shared
0
No disclosed counterparties: BOLT.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Role chip = supplier or customer
Source: SEC EDGAR
BOLT
Bolt Biotherapeutics, Inc.
Change
6.18
▼
−0.98%
· post 6.52
Mkt cap
$12.7M
Revenue
$5,000
Q2 FY26
Revenue
$8M
FY25
LLY
ELI Lilly & Co
Change
1,407.25
▼
−0.27%
· post 1,416.42
Closed
Nov 3 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 3 '26
BOLT
Bolt Biotherapeutics, Inc.
vs
LLY
ELI Lilly & Co
6.18
▼
−0.98%
post 6.52
Price
1,407.25
▼
−0.27%
post 1,416.42
$12.7M
Mkt cap
$1.3T
Q2 FY26
$5,000
Revenue
$24.4B
Q3 FY26
FY25
$8M
Revenue
$65.2B
FY25
Change
Change
BOLT
6.18
▼
−0.98%
vs
LLY
1,407.25
▼
−0.27%
Closed
Nov 3 '26